APO Research
Talk to an analyst

APO RESEARCH · REPORT

2-Cyclopentenone

2-Cyclopentenone is a cyclic unsaturated ketone compound.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Chemical identity, substitution pattern, assay and related impurities define the supplied material. The named chemical category does not establish a finished formulation’s compatibility, end-use approval or performance; those depend on the actual grade and application.

The commercial boundary

Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.

Which supplied interfaces and acceptance criteria define 2-Cyclopentenone?

Chemical identity, substitution pattern, assay and related impurities define the supplied material. The named chemical category does not establish a finished formulation’s compatibility, end-use approval or performance; those depend on the actual grade and application.

Selected research

Market Outlook & Growth Opportunities

Global 2-Cyclopentenone Market Outlook and Growth Opportunities 2026

3 May 2026184 pages

Choose your research edition.

Industry Research2-Cyclopentenone Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal 2-Cyclopentenone Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal 2-Cyclopentenone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 2-Cyclopentenone Market Outlook and Growth Opportunities 2026184 pages · $4,250 USDMarket Analysis & ForecastGlobal 2-Cyclopentenone Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global 2-Cyclopentenone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for 2-Cyclopentenone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 2-Cyclopentenone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 2-Cyclopentenone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the 2-Cyclopentenone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the 2-Cyclopentenone market include Sangon Biotech, TCI, Thermo Fisher, Huida Pharmaceutical and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global 2-Cyclopentenone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 2-Cyclopentenone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 2-Cyclopentenone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 2-Cyclopentenone market size, projected growth trends, production technologies, key applications, and end-use industries.

2-Cyclopentenone Segment by Company

Sangon Biotech

TCI

Thermo Fisher

Huida Pharmaceutical

Merck

2-Cyclopentenone Segment by Type

Purity≥98%

Purity≥99%

Others

2-Cyclopentenone Segment by Application

Organic Synthesis Intermediates

Pharmaceutical Intermediates

2-Cyclopentenone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global 2-Cyclopentenone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions 2-Cyclopentenone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify 2-Cyclopentenone significant trends, drivers, influence factors in global and regions.

6. To analyze 2-Cyclopentenone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 2-Cyclopentenone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 2-Cyclopentenone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 2-Cyclopentenone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the 2-Cyclopentenone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 2-Cyclopentenone industry.

Chapter 3: Detailed analysis of 2-Cyclopentenone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of 2-Cyclopentenone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of 2-Cyclopentenone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. 2-Cyclopentenone Industry Trends Table 2. 2-Cyclopentenone Industry Drivers Table 3. 2-Cyclopentenone Industry Opportunities and Challenges Table 4. 2-Cyclopentenone Industry Restraints Table 5. Global 2-Cyclopentenone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global 2-Cyclopentenone Revenue Share by Company (2021-2026) Table 7. Global 2-Cyclopentenone Sales Volume by Company (t) & (2021-2026) Table 8. Global 2-Cyclopentenone Sales Volume Share by Company (2021-2026) Table 9. Global 2-Cyclopentenone Average Price (USD/t) of Company (2021-2026) Table 10. Global 2-Cyclopentenone Company Ranking, (2024-2026) & (USD Million) Table 11. Global 2-Cyclopentenone Key Company Manufacturing Base & Headquarters Table 12. Global 2-Cyclopentenone Company, Product Type & Application Table 13. Global 2-Cyclopentenone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global 2-Cyclopentenone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity≥98% Table 18. Significant Companies of Purity≥99% Table 19. Significant Companies of Others Table 20. Global 2-Cyclopentenone Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 21. Global 2-Cyclopentenone Sales Volume by Type (2021-2026) & (t) Table 22. Global 2-Cyclopentenone Sales Volume by Type (2027-2032) & (t) Table 23. Global 2-Cyclopentenone Sales Volume Share by Type (2021-2026) Table 24. Global 2-Cyclopentenone Sales Volume Share by Type (2027-2032) Table 25. Global 2-Cyclopentenone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global 2-Cyclopentenone Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global 2-Cyclopentenone Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global 2-Cyclopentenone Sales Value Share by Type (2021-2026) Table 29. Global 2-Cyclopentenone Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Organic Synthesis Intermediates Table 31. Significant Companies of Pharmaceutical Intermediates Table 32. Global 2-Cyclopentenone Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 33. Global 2-Cyclopentenone Sales Volume by Application (2021-2026) & (t) Table 34. Global 2-Cyclopentenone Sales Volume by Application (2027-2032) & (t) Table 35. Global 2-Cyclopentenone Sales Volume Share by Application (2021-2026) Table 36. Global 2-Cyclopentenone Sales Volume Share by Application (2027-2032) Table 37. Global 2-Cyclopentenone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global 2-Cyclopentenone Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global 2-Cyclopentenone Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global 2-Cyclopentenone Sales Value Share by Application (2021-2026) Table 41. Global 2-Cyclopentenone Sales Value Share by Application (2027-2032) Table 42. Global 2-Cyclopentenone Sales by Region: 2021 VS 2025 VS 2032 (t) Table 43. Global 2-Cyclopentenone Sales by Region (2021-2026) & (t) Table 44. Global 2-Cyclopentenone Sales Market Share by Region (2021-2026) Table 45. Global 2-Cyclopentenone Sales by Region (2027-2032) & (t) Table 46. Global 2-Cyclopentenone Sales Market Share by Region (2027-2032) Table 47. Global 2-Cyclopentenone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global 2-Cyclopentenone Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global 2-Cyclopentenone Sales Value Share by Region (2021-2026) Table 50. Global 2-Cyclopentenone Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global 2-Cyclopentenone Sales Value Share by Region (2027-2032) Table 52. Global 2-Cyclopentenone Market Average Price (USD/t) by Region (2021-2026) Table 53. Global 2-Cyclopentenone Market Average Price (USD/t) by Region (2027-2032) Table 54. Global 2-Cyclopentenone Sales by Country: 2021 VS 2025 VS 2032 (t) Table 55. Global 2-Cyclopentenone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global 2-Cyclopentenone Sales by Country (2021-2026) & (t) Table 57. Global 2-Cyclopentenone Sales Market Share by Country (2021-2026) Table 58. Global 2-Cyclopentenone Sales by Country (2027-2032) & (t) Table 59. Global 2-Cyclopentenone Sales Market Share by Country (2027-2032) Table 60. Global 2-Cyclopentenone Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global 2-Cyclopentenone Sales Value Market Share by Country (2021-2026) Table 62. Global 2-Cyclopentenone Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global 2-Cyclopentenone Sales Value Market Share by Country (2027-2032) Table 64. Sangon Biotech Company Information Table 65. Sangon Biotech Business Overview Table 66. Sangon Biotech 2-Cyclopentenone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 67. Sangon Biotech 2-Cyclopentenone Product Portfolio Table 68. Sangon Biotech Recent Development Table 69. TCI Company Information Table 70. TCI Business Overview Table 71. TCI 2-Cyclopentenone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 72. TCI 2-Cyclopentenone Product Portfolio Table 73. TCI Recent Development Table 74. Thermo Fisher Company Information Table 75. Thermo Fisher Business Overview Table 76. Thermo Fisher 2-Cyclopentenone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 77. Thermo Fisher 2-Cyclopentenone Product Portfolio Table 78. Thermo Fisher Recent Development Table 79. Huida Pharmaceutical Company Information Table 80. Huida Pharmaceutical Business Overview Table 81. Huida Pharmaceutical 2-Cyclopentenone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 82. Huida Pharmaceutical 2-Cyclopentenone Product Portfolio Table 83. Huida Pharmaceutical Recent Development Table 84. Merck Company Information Table 85. Merck Business Overview Table 86. Merck 2-Cyclopentenone Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 87. Merck 2-Cyclopentenone Product Portfolio Table 88. Merck Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. 2-Cyclopentenone Distributors List Table 92. 2-Cyclopentenone Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. 2-Cyclopentenone Product Image Figure 2. Global 2-Cyclopentenone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 2-Cyclopentenone Sales Value (2021-2032) & (US$ Million) Figure 4. Global 2-Cyclopentenone Sales (2021-2032) & (t) Figure 5. Global 2-Cyclopentenone Sales Average Price (USD/t) & (2021-2032) Figure 6. Global 2-Cyclopentenone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity≥98% Image Figure 10. Purity≥99% Image Figure 11. Others Image Figure 12. Global 2-Cyclopentenone Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global 2-Cyclopentenone Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global 2-Cyclopentenone Sales Volume Share by Type (2021-2032) Figure 15. Global 2-Cyclopentenone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global 2-Cyclopentenone Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global 2-Cyclopentenone Sales Value Share by Type (2021-2032) Figure 18. Organic Synthesis Intermediates Image Figure 19. Pharmaceutical Intermediates Image Figure 20. Global 2-Cyclopentenone Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 21. Global 2-Cyclopentenone Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global 2-Cyclopentenone Sales Volume Share by Application (2021-2032) Figure 23. Global 2-Cyclopentenone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global 2-Cyclopentenone Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global 2-Cyclopentenone Sales Value Share by Application (2021-2032) Figure 26. Global 2-Cyclopentenone Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 27. Global 2-Cyclopentenone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global 2-Cyclopentenone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global 2-Cyclopentenone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America 2-Cyclopentenone Sales Value (2021-2032) & (US$ Million) Figure 31. North America 2-Cyclopentenone Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe 2-Cyclopentenone Sales Value (2021-2032) & (US$ Million) Figure 33. Europe 2-Cyclopentenone Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific 2-Cyclopentenone Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific 2-Cyclopentenone Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America 2-Cyclopentenone Sales Value (2021-2032) & (US$ Million) Figure 37. South America 2-Cyclopentenone Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa 2-Cyclopentenone Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa 2-Cyclopentenone Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt 2-Cyclopentenone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. 2-Cyclopentenone Value Chain Figure 125. Manufacturing Cost Structure Figure 126. 2-Cyclopentenone Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Purity≥98%
  • Purity≥99%
  • Others
Applications
  • Organic Synthesis Intermediates
  • Pharmaceutical Intermediates
Companies covered
  • Sangon Biotech
  • TCI
  • Thermo Fisher
  • Huida Pharmaceutical
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 2-Cyclopentenone Sales Value (2021-2032)
  4. 1.2.2 Global 2-Cyclopentenone Sales Volume (2021-2032)
  5. 1.2.3 Global 2-Cyclopentenone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 2-Cyclopentenone Market Dynamics
  1. 2.1 2-Cyclopentenone Industry Trends
  2. 2.2 2-Cyclopentenone Industry Drivers
  3. 2.3 2-Cyclopentenone Industry Opportunities and Challenges
  4. 2.4 2-Cyclopentenone Industry Restraints
3 2-Cyclopentenone Market by Company
  1. 3.1 Global 2-Cyclopentenone Company Revenue Ranking in 2025
  2. 3.2 Global 2-Cyclopentenone Revenue by Company (2021-2026)
  3. 3.3 Global 2-Cyclopentenone Sales Volume by Company (2021-2026)
  4. 3.4 Global 2-Cyclopentenone Average Price by Company (2021-2026)
  5. 3.5 Global 2-Cyclopentenone Company Ranking (2024-2026)
  6. 3.6 Global 2-Cyclopentenone Company Manufacturing Base and Headquarters
  7. 3.7 Global 2-Cyclopentenone Company Product Type and Application
  8. 3.8 Global 2-Cyclopentenone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global 2-Cyclopentenone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 2-Cyclopentenone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 2-Cyclopentenone Market by Type
  1. 4.1 2-Cyclopentenone Type Introduction
  2. 4.1.1 Purity≥98%
  3. 4.1.2 Purity≥99%
  4. 4.1.3 Others
  5. 4.2 Global 2-Cyclopentenone Sales Volume by Type
  6. 4.2.1 Global 2-Cyclopentenone Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global 2-Cyclopentenone Sales Volume by Type (2021-2032)
  8. 4.2.3 Global 2-Cyclopentenone Sales Volume Share by Type (2021-2032)
  9. 4.3 Global 2-Cyclopentenone Sales Value by Type
  10. 4.3.1 Global 2-Cyclopentenone Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global 2-Cyclopentenone Sales Value by Type (2021-2032)
  12. 4.3.3 Global 2-Cyclopentenone Sales Value Share by Type (2021-2032)
5 2-Cyclopentenone Market by Application
  1. 5.1 2-Cyclopentenone Application Introduction
  2. 5.1.1 Organic Synthesis Intermediates
  3. 5.1.2 Pharmaceutical Intermediates
  4. 5.2 Global 2-Cyclopentenone Sales Volume by Application
  5. 5.2.1 Global 2-Cyclopentenone Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global 2-Cyclopentenone Sales Volume by Application (2021-2032)
  7. 5.2.3 Global 2-Cyclopentenone Sales Volume Share by Application (2021-2032)
  8. 5.3 Global 2-Cyclopentenone Sales Value by Application
  9. 5.3.1 Global 2-Cyclopentenone Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global 2-Cyclopentenone Sales Value by Application (2021-2032)
  11. 5.3.3 Global 2-Cyclopentenone Sales Value Share by Application (2021-2032)
6 2-Cyclopentenone Regional Sales and Value Analysis
  1. 6.1 Global 2-Cyclopentenone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global 2-Cyclopentenone Sales by Region (2021-2032)
  3. 6.2.1 Global 2-Cyclopentenone Sales by Region: 2021-2026
  4. 6.2.2 Global 2-Cyclopentenone Sales by Region (2027-2032)
  5. 6.3 Global 2-Cyclopentenone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global 2-Cyclopentenone Sales Value by Region (2021-2032)
  7. 6.4.1 Global 2-Cyclopentenone Sales Value by Region: 2021-2026
  8. 6.4.2 Global 2-Cyclopentenone Sales Value by Region (2027-2032)
  9. 6.5 Global 2-Cyclopentenone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America 2-Cyclopentenone Sales Value (2021-2032)
  12. 6.6.2 North America 2-Cyclopentenone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe 2-Cyclopentenone Sales Value (2021-2032)
  15. 6.7.2 Europe 2-Cyclopentenone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific 2-Cyclopentenone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific 2-Cyclopentenone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America 2-Cyclopentenone Sales Value (2021-2032)
  21. 6.9.2 South America 2-Cyclopentenone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa 2-Cyclopentenone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa 2-Cyclopentenone Sales Value Share by Country, 2025 VS 2032
7 2-Cyclopentenone Country-level Sales and Value Analysis
  1. 7.1 Global 2-Cyclopentenone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global 2-Cyclopentenone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global 2-Cyclopentenone Sales by Country (2021-2032)
  4. 7.3.1 Global 2-Cyclopentenone Sales by Country (2021-2026)
  5. 7.3.2 Global 2-Cyclopentenone Sales by Country (2027-2032)
  6. 7.4 Global 2-Cyclopentenone Sales Value by Country (2021-2032)
  7. 7.4.1 Global 2-Cyclopentenone Sales Value by Country (2021-2026)
  8. 7.4.2 Global 2-Cyclopentenone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt 2-Cyclopentenone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt 2-Cyclopentenone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt 2-Cyclopentenone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sangon Biotech
  2. 8.1.1 Sangon Biotech Company Information
  3. 8.1.2 Sangon Biotech Business Overview
  4. 8.1.3 Sangon Biotech 2-Cyclopentenone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sangon Biotech 2-Cyclopentenone Product Portfolio
  6. 8.1.5 Sangon Biotech Recent Developments
  7. 8.2 TCI
  8. 8.2.1 TCI Company Information
  9. 8.2.2 TCI Business Overview
  10. 8.2.3 TCI 2-Cyclopentenone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 TCI 2-Cyclopentenone Product Portfolio
  12. 8.2.5 TCI Recent Developments
  13. 8.3 Thermo Fisher
  14. 8.3.1 Thermo Fisher Company Information
  15. 8.3.2 Thermo Fisher Business Overview
  16. 8.3.3 Thermo Fisher 2-Cyclopentenone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Thermo Fisher 2-Cyclopentenone Product Portfolio
  18. 8.3.5 Thermo Fisher Recent Developments
  19. 8.4 Huida Pharmaceutical
  20. 8.4.1 Huida Pharmaceutical Company Information
  21. 8.4.2 Huida Pharmaceutical Business Overview
  22. 8.4.3 Huida Pharmaceutical 2-Cyclopentenone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Huida Pharmaceutical 2-Cyclopentenone Product Portfolio
  24. 8.4.5 Huida Pharmaceutical Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck 2-Cyclopentenone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merck 2-Cyclopentenone Product Portfolio
  30. 8.5.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 2-Cyclopentenone Value Chain Analysis
  2. 9.1.1 2-Cyclopentenone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 2-Cyclopentenone Sales Mode & Process
  6. 9.2 2-Cyclopentenone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 2-Cyclopentenone Distributors
  9. 9.2.3 2-Cyclopentenone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst